Treating and Preventing Adolescent Mental Health Disorders: Treating and Preventing Adolescent Mental Health Disorders

Home > Table of Contents

Book Title: Treating and Preventing Adolescent Mental Health Disorders > pp. [806]

UNDEFINED: AUTHORS

Treating and Preventing Adolescent Mental Health Disorders

Print ISBN 9780195173642, 2005
pp. [806]

Negative affectivity

bulimia nervosa and , 313

and vulnerability to depression , 10–11

Negative cognitions, and vulnerability to depression , 11–12

Negative life events

anorexia nervosa and , 310

social support and , 231

suicidal behavior and , 439–40

Negative self-talk, reduction, for anxiety disorders , 185

Negative symptoms, in schizophrenia , 82

Networks of care, interorganizational, for substance abuse treatment , 575–76

Neuregulin 1, as schizophrenia susceptibility gene , 104

Neuroanatomic studies, in schizophrenia , 85–88

Neurobehavioral deficits, in schizophrenia , 83–85

Neurobiology

anxiety disorders , 176–81 , 186–87

schizophrenia , 82–97 , 142

substance use disorders , 372–84

Neurochemistry, anxiety disorders , 178

Neuroendocrine changes

during adolescence , xxxi, 96

child abuse and , 26

in eating disorders , 276 t

in schizophrenia , 95–97

Neurogenesis, postnatal , xxxi

Neuroimaging

in anxiety disorders , 178–79

in mood disorders , 26–27

in schizophrenia , 86–88

in substance use disorders , 380–84

Neurologic signs, in schizophrenia, premorbid abnormalities , 145 t, 146 , 148 , 149

Neuropsychological deficits, in children of schizophrenic parents , 153

Neuroticism

as risk factor for psychopathology , 11

and vulnerability to depression , 10–11

Neurotransmitter systems . See also specific types, e.g., Serotonin

in anxiety disorders , 187

maturation , xxxi

New York, reform initiatives on delivery of evidence-based practices , 556

Nicotine receptors, smoking and , 386

Nicotine-replacement therapy (NRT), 405

Novelty, amygdala response to , 176–77

Np (processing negativity), in schizophrenia, 93 t, 94

Nurse, school , 605 t

Nurse practitioner, school-based , 605 t

Obesity

anorexia nervosa and , 308

bulimia nervosa and , 313–14

depression and , 9

professionally administered weight loss programs for , 316–19

as risk factor for eating disorders , 315–19 , 331–32

Obsessive-compulsive disorder

in children and adolescents , 205–6

description , 164 , 166

plus eating disorders , 272 , 273

genetics , 180 t

PANDAS subgroup , 205–6 , 209

rating scale , 235

signs and symptoms , 165 t

treatment , 190t–191 t, 214 t

in adults , 204–5

in children and adolescents , 206–9

investigational , 209

maintenance of gains , 216

management of partial response and nonresponse to , 218–19

Obstetrics-gynecology, and early detection and screening of anxiety disorders , 235

OCD . See Obsessive-compulsive disorder

Ohio, reform initiatives on delivery of evidence-based practices , 556

Olanzapine

for anorexia nervosa , 292

for bipolar disorder

in adolescents , 52–53 , 52 t

in adults , 50–51

for post-traumatic stress disorder , 219

for schizophrenia , 121 t, 123 t, 124 t, 125

Ondansetron, for bulimia nervosa , 294

Onset

first (initial), definition , xxxv, 58

risk of, versus risk of relapse , xxxv, 59

Opioid abuse

behavioral therapy , 396

clinical aspects , 347–49 , 347 t, 349 t

detoxification , 403–4

genetics , 388

medications for long-term treatment , 406

withdrawal , 348–49 , 349 t

Opioid pain relievers , 347 t, 348

Opioid system, alcohol abuse and , 387–88

Oppositional disorder, plus anxiety , 170

Organizational context, impact on service delivery , 557–60

Organizations

climate , 558

culture , 558

effectiveness studies , 559

leadership , 559

readiness to change , 559

structure , 558

work attitudes , 559

end p.806